LPL Financial
RLAY icon

LPL Financial’s Relay Therapeutics RLAY Stock Holding History

LPL Financial’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Buy
48,415
+7,952
+20% +$115K ﹤0.01% 4507
2026
Q1 		$403K Buy
40,463
+6,319
+19% +$56.5K ﹤0.01% 4962
2025
Q4 		$289K Sell
34,144
-7,784
-19% -$55.5K ﹤0.01% 5167
2025
Q3 		$219K Buy
41,928
+17,100
+69% +$65.2K ﹤0.01% 5287
2025
Q2 		$85.9K Hold
24,828
– – ﹤0.01% 5291
2025
Q1 		$65K Buy
24,828
+210
+0.9% +$823 ﹤0.01% 5122
2024
Q4 		$101K Sell
24,618
-6,564
-21% -$35.7K ﹤0.01% 4997
2024
Q3 		$221K Sell
31,182
-5,200
-14% -$38.8K ﹤0.01% 4662
2024
Q2 		$237K Buy
+36,382
New +$249K ﹤0.01% 4437

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

LPL Financial's RLAY Position: Q2 2026 in Review

LPL Financial increased its Relay Therapeutics (RLAY) stake by 20% in Q2 2026, buying an estimated $115K and bringing the position to 48,415 shares worth $906K. The position accounts for ﹤0.01% of the portfolio, ranked #4507.

LPL Financial first reported a position in RLAY in Q2 2024 and has held it in 9 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • LPL Financial held 48,415 shares of Relay Therapeutics worth $906K as of Q2 2026.
  • LPL Financial bought 7,952 Relay Therapeutics shares in Q2 2026, an estimated $115K.
  • Relay Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4507 holding.
  • LPL Financial first reported a position in Relay Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.